| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.912 | 44.712 | 36.543 | 33.370 | 34.533 | 28.734 | 30.006 | 36.075 | 26.116 | 21.924 |
| Total Income - EUR | 34.682 | 44.196 | 37.071 | 33.828 | 34.599 | 28.734 | 37.924 | 36.075 | 26.116 | 23.921 |
| Total Expenses - EUR | 29.728 | 27.058 | 29.192 | 24.798 | 30.650 | 27.979 | 19.929 | 30.846 | 24.302 | 13.919 |
| Gross Profit/Loss - EUR | 4.954 | 17.138 | 7.879 | 9.030 | 3.949 | 755 | 17.994 | 5.229 | 1.813 | 10.002 |
| Net Profit/Loss - EUR | 3.912 | 16.340 | 7.508 | 8.692 | 3.621 | 490 | 17.623 | 4.876 | 1.424 | 8.397 |
| Employees | 3 | 2 | 2 | 2 | 3 | 2 | 1 | 1 | 2 | 1 |
Check the financial reports for the company - Expomeda Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.838 | 9.614 | 4.349 | 3.800 | 3.454 | 2.138 | 1.423 | 1.052 | 803 | 317 |
| Current Assets | 11.269 | 14.710 | 18.385 | 5.895 | 10.819 | 3.341 | 17.553 | 7.511 | 4.647 | 11.511 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.905 | 0 | 0 |
| Receivables | 0 | 2.209 | 6.595 | 94 | 0 | 147 | 0 | 3.701 | 33 | 33 |
| Cash | 11.269 | 12.501 | 11.790 | 5.801 | 10.819 | 3.194 | 17.553 | 905 | 4.613 | 11.478 |
| Shareholders Funds | 25.250 | 22.581 | 21.147 | 8.743 | 12.195 | 4.824 | 18.084 | 5.338 | 3.089 | 9.284 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 45 | 44 | 45 | 44 | 44 |
| Debts | 1.857 | 1.743 | 1.588 | 951 | 2.078 | 656 | 892 | 3.225 | 2.361 | 2.544 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6622 - 6622" | |||||||||
| CAEN Financial Year |
6622
|
|||||||||
Comments - Expomeda Srl